SOURCE: IBC Life Sciences

March 04, 2008 11:30 ET

New Programming Added to IBC Life Sciences' TIDES® Conference Agenda

Organizers Forecast Record Turn-Out at the Event in Las Vegas

WESTBOROUGH, MA--(Marketwire - March 4, 2008) - IBC's Life Sciences is pleased to release new programming for TIDES Oligonucleotide and Peptide® Technology and Product Development Conference which was first released earlier this year. The program now includes the addition of a new course, two new speakers who will present late-breaking data on peptide drugs preclinical and clinical development, and a new panelist in the discussion session on intellectual property.

Program Updates Include:

A half day course entitled "A Lifecycle View of Writing and Filing a CTD/eCTD Submission" given by Co-Instructors: James Blackwell, Ph.D., Senior Consultant, and Alex Kanarek, Ph.D., Quality Consultant, BioProcess Technology Consultants, Inc.

New presentation in the optimization strategies of leading peptides in preclinical development session entitled "The Development of Hotspot Pharmacophores (HPs) for the Treatment of Cancer and Other Disease Indications" by Neil I. Goldstein, Ph.D., President, Antyra Inc.

New presentation in the development strategies of leading peptides in clinical development session on a peptide product from discovery to phase 3 clinical trials by Claudio D. Schteingart, Ph.D., Senior Director of Chemistry, Ferring Research Institute Inc.

In addition, Janet M. McNicholas, Ph.D., Partner, Bell, Boyd and Lloyd, LLP, has been added to the 90-minute discussion panel on intellectual property, in which audience members can ask their questions to the experts about Patent Strategies in Light of the New Rules. The panel is moderated by Richard Warburg, Ph.D., Partner, Foley & Lardner LLP, and Dr. McNicholas is joining other panelist Chris Steinhardt, Partner, Knobbe Martens Olson and Bear LLP.

TIDES® will take place on May 18-21, 2008 at the Red Rock Resort in Las Vegas. For complete and up-to-date programming for this event visit: www.IBCLifeSciences.com/TIDES

About TIDES®

TIDES® is the only US conference that focuses on the challenges of the manufacture and development of therapeutics, vaccines, diagnostics and research tools using oligonucleotides and peptides. Since its inception in 1999 the TIDES program has grown steadily, drawing nearly 700 participants, 75 exhibits, and 20 scientific sessions in 2007. Attendees who return each year say that TIDES is truly the only forum that where they can get updates on the manufacturing-related issues of these molecules. www.IBCLifeSciences.com/TIDES

Contact Information